로딩 중…
지수 로딩 중…
Olema Pharmaceuticals, Inc.
OLMA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$9.49+0.53%
2026-06-18
Price Chart
Olema Pharmaceuticals, Inc.+131.46%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $829M |
| Revenue | $0.00 |
| Net Income | $-185M |
| Total Assets | $531M |
| Net Assets | $480M |
| Value | |
| P/B | 1.73x |
| FCF Yield | -17.94% |
| Profitability | |
| ROE | -38.53% |
| ROA | -34.89% |
| Financial Health | |
| Debt Ratio | 10.44% |
| Total Debt | $956000.00 |
| FCF | $-149M |
| Cash | $53M |
| Current Ratio | 10.88x |
| Performance | |
| 1Y Return | 131.46% |
| 1M Return | -27.56% |
| From 52W High | -73.83% |
| 1Y MDD | -74.35% |
| Trading | |
| Volume | 1,052,817 shares |
| Trading Value | $10M |
| Per Share | |
| EPS | $-1.78 |
| BPS | $5.24 |